Voice Prosthesis Devices And Equipment Global Market Report 2023 – By Device Type (Indwelling Voice Prosthesis Devices, Non-Indwelling Voice Prosthesis Devices), By Product Type (Soft Valve Assembly, Hard Valve Assembly, Other Product Types), By Valve Type (Blom-Singer valve, Provox valve, Groningen valve), By Material (Silicone Rubber, Silicone, Fluoroplastic, Silver Oxide, Other Materials), By End User (Hospitals, Ambulatory Surgical Centers, Clinics) – Market Size, Trends, And Global Forecast 2023-2032

The laryngoscope is a medical device used to view and examine the larynx and vocal cords in the throat. This device is also used during tracheal intubation in patients requiring ventilator support. The main types of the laryngoscope market are indirect laryngoscope and direct laryngoscope. The direct laryngoscope is the procedure that allows visualization of the larynx during general anesthesia, surgical procedures. The various product involved is video laryngoscopes, standard laryngoscopes, and fiber-optic laryngoscopes. The various end-users are hospitals, clinics, and medical examination centers. The global laryngoscope market is segmented – 1) By Type: Indirect Laryngoscope, Direct Laryngoscope 2) By Product: Video Laryngoscopes, Standard Laryngoscopes, Fiber-optic Laryngoscopes 3) By End-user: Hospitals, Clinics, Medical Examination Center The global laryngoscope market size grew from $0.25 billion in 2022 to $0.28 billion in 2023 at a compound annual growth rate (CAGR) of 11.1%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of global laryngoscope is expected to grow from $0.41 billion in 2027 at a CAGR of 10.0%. The growing prevalence of laryngeal cancers, infections, and chronic respiratory diseases are one of the key reasons expected to boost laryngoscope market growth. Laryngeal cancer is head and neck cancer that occurs when abnormal (malignant) cells form in the larynx. In2020, approximately 99,840 people died of laryngeal cancer worldwide. Moreover, in 2020, in the United States, there were 12,370 new cases and 3,750 deaths from laryngeal cancer. Therefore, the increasing prevalence of laryngeal cancer increased the demand for laryngoscopes and thereby contributed to growth of the laryngoscopes market. Major players in the laryngoscope market are Ambu, Hill-Rom Holdings, Inc., KARL STORZ, Medtronic, Olympus, HOYA, Roper Technologies, Inc. (Verathon, Inc.), Richard Wolf GmbH, Schoelly Fiberoptic GmbH, and Welch Allyn Inc. Soft tissue injury caused by a laryngoscope is a restraining factor for the laryngoscope market. The most common complication is an injury to the soft palate, although injuries also occur to the teeth, larynx, tongue, and retromolar trigone. The oropharynx is specifically at risk of injury because the video laryngoscope causes the tonsillar pillars to elevate and stretch anteriorly, making them more prone to injury as the tube is being advanced. The soft tissue damage in traditional laryngoscopy is caused mainly by insertion of the laryngoscope, but soft tissue injury with the video laryngoscope is caused by insertion of the endotracheal tube (ETT) itself, as it is often designed blindly into and through the oral cavity and pharynx until it is finally in view at the video laryngoscope monitor. The complications caused demand for a better device, restraining the laryngoscope market. Robot-assisted laryngoscopy is one of the key trends shaping the laryngoscope market. Growing complications or risks associated with advanced and experimental procedures contribute to increased demand for robot-assisted laryngoscopy. The characteristics of robot-assisted devices such as reliability will increase precision levels and have near-absolute geometric accuracy, which helps to reduce the workload of the specialists and improve patient care. Implementing robotic systems leads to faster skill development than manual procedures, and also improves performance and safety. Johns Hopkins University developed a robotic tool to improve surgeons' access to the larynx (voice box). The experts are designing a robotic laryngoscope that can be used with one hand like a joystick. Asia-Pacific was the largest region in the laryngoscopes market in 2022. North America was the second largest region in the laryngoscope market share. Eastern Europe was the smallest region in the global laryngoscope market report. The regions covered in the global laryngoscope market analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the laryngoscopes market are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA. The laryngoscopes market consists of sales of fiber optic laryngoscopes, video laryngoscopes, and standard/conventional laryngoscopes. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The laryngoscopes market research report is one of a series of new reports from The Business Research Company that provides laryngoscope market statistics, including laryngoscope industry size, regional shares, competitors with a laryngoscope market share, detailed laryngoscope market segments, market trends and opportunities, and any further data you may need to thrive in the laryngoscope industry. This laryngoscope market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The ENT devices are used in the diagnosis and treatment of ear, nose, and throat diseases. The main types of ENT devices are hearing aid devices and equipment, hearing diagnostic devices and equipment, ENT surgical devices and equipment, hearing implants, voice prosthesis devices and equipment, and nasal splints. A hearing aid device is an electronic device that is worn in or behind the ear. It makes sounds louder so that a person with hearing loss can listen, communicate, and participate fully in daily activities. The type of expenditure is public and private. The products used are instruments/equipment and disposables. The various end-users are hospitals and clinics, diagnostic laboratories, and others. The global ent devices market is segmented - 1) By Type: Hearing Aid Devices And Equipment, Hearing Diagnostic Devices And Equipment, ENT Surgical Devices And Equipment, Hearing Implants, Voice Prosthesis Devices And Equipment, Nasal Splints 2) By End User: Hospitals And Clinics, Diagnostic Laboratories, Other End Users 3) By Type of Expenditure: Public, Private 4) By Product: Instruments/Equipment, Disposables The global ent devices market size grew from $30.21 billion in 2022 to $32.98 billion in 2023 at a compound annual growth rate (CAGR) of 9.2%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of global ent devices is expected to grow to $45.04 billion in 2027 at a CAGR of 8.1%. Many governments across the world have introduced new healthcare acts and continuously increased healthcare spending. Healthcare coverage and expenditure also increased significantly. In 2021, the Indian government launched Ayushman Bharat PradhanMantri Jan ArogyaYojana (AB-PMJAY) is providing health assurance cover of up to ?5 Lakh per year per family for secondary and tertiary healthcare hospitalizations. Favourable government decisions and increased healthcare spending increased the demand for healthcare services and this drove the demand for the growth of the ENT devices market during this period. Major companies in the ENT devices market include Sonova Holdings AG, William Demant Holdings A/S, Medtronic Inc., GN Store Nord A/S, Cochlear Limited, Olympus Corporation, Stryker Corporation, Karl Storz SE & Co KG, Merck & Co, and Smith & Nephew plc. Interest rates globally are forecasted to rise in most of the developing and developed economies during the forecast period; this is expected to limit new investments in the market. Most countries across the world are raising interest rates to control inflation and also to limit the flow of capital out of the country. This is likely to affect new investments in terms of expansion, research, and development of new products. For instance, the US interest rates are expected to rise to 3.5% by 2021. These factors are expected to have a negative impact on the market as borrowing money becomes expensive, thereby affecting the market growth. ENT device manufacturers are investing in technologies to develop user-friendly and non-invasive equipment. They are continuously investing funds and resources into R&D to increase the scope of their devices. For instance, Intersect ENT developed Propel Mometasone Furoate Implant (PMFI) to treat chronic sinusitis. It is a bio-absorbable steroid that is placed directly into the sinus mucosa. It controls the release of drugs and dissolves over time. In another breakthrough in sinusitis treatment, SinuSys Corporation received FDA approval for its Vent-Os Sinus Dilation device. It is a small, low-pressure insert that is designed to gently open the sinus ostia and use the body’s natural mucosal fluids to expand the device. Asia-Pacific was the largest region in the global ENT devices market in 2022. North America was the second largest region in the global ENT devices market share. Africa. was the smallest region in the global ENT devices market analysis. The regions covered in the ENT devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the ENT devices market are Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa., South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, UAE, UK, USA, Venezuela, and Vietnam. The ENT devices market consists of sales of instruments such as Pure tone and impedance audiometers, BERA and OAE screening machines, nerve stimulators, and high-end microdrill that are used for diagnosis and treatment of ENT diseases. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The ENT devices market research report is one of a series of new reports from The Business Research Company that provides ENT devices market statistics, including ENT devices industry global market size, regional shares, competitors with an ENT devices market share, detailed ENT devices market segments, market trends and opportunities, and any further data you may need to thrive in the ENT devices industry. This ENT devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

ENT surgical devices and equipment are used in ENT surgeries by surgeons and ENT specialists. The main products in ENT surgical devices and equipment are hand instruments, ENT surgical lasers, powered ENT surgical systems, radiofrequency electrosurgical devices, ENT surgery workstations, an ENT surgical navigation system, an ENT visualization system, and surgical microscopes. These devices and equipment are hand-held devices, portable devices, and fixed devices. The various end-users are hospitals, ambulatory surgical centres, and ENT clinics. The global ent surgical devices and equipment market is segmented - 1) By Modality: Hand-held devices, Portable devices, Fixed devices 2) By End User: Hospitals, Ambulatory surgical centers, ENT Clinics 3) By Product: Hand Instrument, ENT Surgical Lasers, Powered ENT Surgical Systems, Radiofrequency Electrosurgical Devices, ENT Surgery Workstations, ENT Surgical Navigation System, ENT Visualization System, Surgical Microscopes The global ent surgical devices and equipment market size will grow from $6.25 billion in 2022 to $6.81 billion in 2023 at a compound annual growth rate (CAGR) of 8.9%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of the ent surgical devices and equipment is expected to grow to $9.11 billion in 2027 at a CAGR of 7.5%. Increasing demand and adoption of minimally invasive ENT surgeries will drive the ENT surgical devices and equipment market in the future. For example, minimally invasive ENT surgeries offer patients many benefits such as smaller incisions, faster recovery times, reduced pain, and scarring. In the majority of the cases, physicians enjoy a higher accuracy rate compared to traditional open surgery. These supreme benefits of minimally invasive ENT surgeries will drive the ent surgical devices and equipment market. Major players in the ENT surgical devices and equipment market are Carl Zeiss Meditec AG, Stryker, Shanghai Fosun Pharmaceuticals Ltd., KLS Martin LP, Acclarent Inc., Medtronic, Smith & Nephew, Boston Scientific, Olympus, and ClaroNav. Lack of proper reimbursement policies for ENT surgical procedures, especially in developing and developed countries, is one of the major factors that could hinder the growth of the ENT surgical devices and equipment market. ENT surgical procedures are complex, involve greater devices, and thus are relatively expensive. The lack of proper reimbursement policies may inhibit the growth of the ENT surgical devices and equipment market. ENT procedures involving minimally invasive ENT tools are an alternative to major surgeries. It involves less tissue damage, reduced scarring, and faster recovery thereby leading to greater adoption and would see an increase in the market potential. Robot-assisted minimally invasive ENT procedures have transformed the treatment landscape of cancer associated with the ear, nose, and throat. For treating benign and malignant conditions of the oropharynx and larynx, Transoral robotic surgery (TORS) is now being widely adopted. The ENT surgical devices and equipment industry has lately witnessed a rise in the number of FDA clearances which would positively impact the market growth. A pre-market approval by FDA through FDA 510(K) is required for all the medical devices including ENT surgical devices. As announced by the FDA, the FDA 510(K) is expected to see several updates to regulate safety, technology, and capabilities in the medical devices space. The European Union’s Medical Device Regulation (MDR) presented a few changes that would come into force by 2020. The changes made to the regulation were in terms of recertification of legacy devices, as well as changes in the definition of regulated devices, safety measures, and risk management. In 2020, Intersect ENT, a USA-based ear, nose, and throat condition treatment developer, announced to acquire Fiagon for USD 71.1 million. The acquisition was aimed to help Intersect ENT to expand its product portfolio and to extend its geographical reach. Fiagon develops surgical navigation systems that support both routine and complex ENT procedures and is based in Germany. Asia-Pacific was the largest region in the global ENT surgical devices and equipment market in 2022. North America was the second-largest region in the ENT surgical devices and equipment market share. The regions covered in the global ENT surgical devices and equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in ENT surgical devices and equipment market are Brazil, China, France, Germany, India, Indonesia, Japan, South Korea, Russia, the UK, the USA, and Australia. The ENT surgical devices and equipment market consists of sales of balloon sinus dilation devices, powered surgical instruments, ENT supplies, radiofrequency devices, ear tubes, and handheld instruments including the otology instrument, rhinology instrument, head and neck surgical instrument, laryngeal instrument, and other handheld instruments that are used for ENT surgeries. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The ENT surgical devices and equipment market research report is one of a series of new reports from The Business Research Company that provides ENT surgical devices and equipment market statistics, including ENT surgical devices and equipment industry global market size, regional shares, competitors with a ENT surgical devices and equipment market share, detailed ENT surgical devices and equipment market segments, market trends and opportunities, and any further data you may need to thrive in the ENT surgical devices and equipment industry. This ENT surgical devices and equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Hearing diagnostic devices and equipment are used for testing and evaluating hearing loss. These devices usually consist of an embedded hardware unit connected to a pair of headphones and a test subject feedback button, sometimes controlled by a standard personal computer. The main types of hearing diagnostic devices and equipment market are otoacoustic emission (OAE), audiometer, otoscope, tympanometry, and others. Otoacoustic emissions (OAEs) are sounds of cochlear origin that are recorded by a microphone fitted into the ear canal. These are used for indications such as conductive hearing loss, sensorineural hearing loss, and combination hearing loss. The end-users involved are hospitals, clinics, personal use, and ambulatory care settings. The global hearing diagnostic devices and equipment market is segmented - 1) By Type: Otoacoustic emission (OAE), Audiometer, Otoscope, Tympanometer, Other Types 2) By Indication: Conductive Hearing Loss, Sensorineural Hearing Loss, Combination Hearing Loss 3) By End User: Hospitals, Clinics, Personal Use, Ambulatory care settings The global hearing diagnostic devices and equipment market size will grow from $1.97 billion in 2022 to $2.2 billion in 2023 at a compound annual growth rate (CAGR) of 11.7%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of global hearing diagnostic devices and equipment is expected to grow from $3.23 billion in 2027 at a CAGR of 10.1%. Growth in the hearing diagnostic devices and equipment market is attributed to the increasing number of hearing loss cases. This increased prevalence of hearing loss is due to noise pollution, hearing diseases, ototoxic medications, hereditary disorders, birth complications, and a rising geriatric population. According to World Health Organization (WHO), the hearing diagnostic device market is expected to make enormous advancements and investments in hearing diagnostic devices and equipment even as the number of affected individuals is expected to increase to 900 million by 2050 in the world. According to the National Institute on Deafness and Other communication, disorders states that approximately one in three people in the United States between the ages of 65 and 74 have hearing loss, and half of those older than 75 have difficulty hearing. Hence, the rising prevalence of hearing disorders and losses drives the hearing diagnostic devices and equipment market growth. Major players in the hearing diagnostic devices and equipment market are Natus Medical, Maico Diagnostics, Inventis, William Demant, Amplivox, Welch Allyn, Grason Stadler, Interacoustics, Rion, and Sivantos. The unaffordability of healthcare equipment in middle-income countries acts as a major factor hindering the development of the hearing diagnostic device and equipment market. The hearing diagnostic device and equipment market includes advanced technologies and devices for diagnosis, testing, and evaluating hearing loss. The financial inability of remote regions within these middle-income countries, lack of proper infrastructure and healthcare services may hinder the market growth. According to World Bank data, out of the total world population of 7 billion, 5 billion belong to middle-income countries. The hearing healthcare industry is evolving with continuous innovations in terms of technologies used. These technologies use modules like Transient evoked otoacoustic emissions (TEOAE), Distortion product otoacoustic emissions (DPOAE), and Auditory Brainstem Response (ABR). TEOAE is the module that is used for hearing diagnosis and are generated by reflection of traveling wave. DPOAE is used to track the progress of cochlear function in newborns. The ABR is another test used by audiologists to check the way hearing nerves of babies respond to sounds. For example, Maico has invested and recently launched a new product named easy screen with BERAphone that is a combination of ABR, TEOAE, and DPOAE that are used for response detection, reduces the workload, and test time. The European Commission adopted two new regulations for medical devices to enhance safety, take effective measures in the event of concerns, and improve traceability. These regulations provide the medical device manufacturers with a stronger mandate for assessment of medical devices by independent notified bodies, a unique identification number for improving traceability throughout the supply chain, availability of clinical data on devices, and provides a central database to provide patients, healthcare professionals and the public with comprehensive information on products. These rules will help manufacturers to meet the standards, safety requirements and to make better-informed decisions. North America was the largest region in the global hearing diagnostic devices and equipment market in 2022. Asia-Pacific was the second-largest market in the hearing diagnostic devices and equipment market report. The regions covered in the hearing diagnostic devices and equipment industry report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the hearing diagnostic devices and equipment market are Brazil, China, France, Germany, India, Indonesia, Japan, South Korea, Russia, the UK, the USA, and Australia. The hearing diagnostic devices and equipment market consists of sales of otoacoustic emission (OAE), audiometer, otoscope, tympanometer, and other hearing diagnostic devices that are used for testing and evaluating the hearing loss. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The hearing diagnostic devices and equipment market research report is one of a series of new reports from The Business Research Company that provides hearing diagnostic devices and equipment market statistics, including hearing diagnostic devices and equipment industry global market size, regional shares, competitors with a hearing diagnostic devices and equipment market share, detailed hearing diagnostic devices and equipment market segments, market trends and opportunities, and any further data you may need to thrive in the hearing diagnostic devices and equipment industry. This hearing diagnostic devices and equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Hearing aids are devices and equipment that are designed and developed to improve the hearing of people affected by hearing loss. The main products of hearing aid devices and equipment are receiver-in-the-ear hearing aids and behind-the-ear hearing aids. A hearing aid receiver works as the ears’ speaker system. It plays the amplified sounds received from the microphone in your ear, and the brain gives the context of the sound. The patients are adults and children. Adult and pediatric patients with conductive hearing loss and sensorineural hearing loss are treated using technologies such as conventional hearing aids and digital hearing aids. The distribution channels are audiology and ENT clinics, pharmacies, online sales, and others. The global hearing aid devices and equipment market size will grow from $10.21 billion in 2022 to $10.9 billion in 2023 at a compound annual growth rate (CAGR) of 6.7%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of global hearing aid devices and equipment is expected to grow from $13.97 billion in 2027 at a CAGR of 6.4%. The growing prevalence of hearing loss is a major driver for hearing aid devices and equipment market growth. In the United States, more than 35 million children and adults have some degree of hearing loss. Also, around 900 million people across the globe are expected to suffer from hearing disabilities by 2050 due to the rise in noise pollution levels, genetic factors, ear infections, and other complications. A high number of people suffering from hearing loss would result in huge demand for hearing aid devices and equipment markets across the globe. Major players in the hearing aid devices and equipment market are Starkey, Sonova, Widex, Siemens, GN ReSound, Oticon, Unitron, Hansaton, William Demant, and Beltone. The high cost of hearing aid devices is acting as a major restraint in the hearing aid devices and equipment market. Good quality hearing aids come at a high price and are not fully covered by insurance companies. About one-third of Americans above 55 years use hearing aid devices due to various reasons. Hearing aid devices range between $1500 to $3500 per piece, thus making them quite expensive. The average price is $2,300 per unit according to the President’s Council for Science & Technology. Thus due to high cost, there has been low penetration of hearing aid devices in the hearing aid devices and equipment market. The use of 3D Printing is a trend that is prevalent in the hearing aid devices market. 3D printing is a technology that produces 3D objects from the 2D models which enable the manufacturing of better fitting, more comfortable, and customized hearing aid devices. The 3D printing enables the shape of the ear shell to be customized according to the customer's ear canal and degree of hearing loss. For example, Sonova uses advanced 3D printing technology to produce customized hearing aid devices especially suited for each customer's specific requirements. Examples of 3D hearing aid devices include EnvisionTEC’s E-Shell 200 Series, E-Shell 300 3D Printer Material series, and EnvisionTEC E-Clear series. As of today, the hearing aids fall under the restricted devices category, the sales of these restricted devices must comply with federal and state requirements. The US FDA approach to improve hearing aid accessibility may lead to the availability of these restricted devices as OTC devices. However, according to the FDA Reauthorization Act (FDARA), the category of OTC hearing aids needs to be established and no manufacturer can label their devices as OTC until a separate category is established. Thus, the introduction of these innovative and easily accessible OTC hearing aids may impact the growth of the hearing aid devices market positively in the forecast period. Asia-Pacific was the largest region in the global hearing aid devices and equipment market in 2022. North America was the second-largest region in the hearing aid devices and equipment market report. The regions covered in the hearing aid devices and equipment analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the hearing aid devices and equipment market are Brazil, China, France, Germany, India, Indonesia, Japan, South Korea, Russia, the UK, the USA, and Australia. The hearing aid devices and equipment market consists of sales of in-the-ear-hearing aid, receiver-in-the-ear hearing aid, behind-the-ear hearing aid, and canal hearing aids. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The hearing aid devices and equipment market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The hearing aid devices and equipment market research report is one of a series of new reports from The Business Research Company that provides hearing aid devices and equipment market statistics, including hearing aid devices and equipment industry global market size, regional shares, competitors with a hearing aid devices and equipment market share, detailed hearing aid devices and equipment market segments, market trends and opportunities, and any further data you may need to thrive in the hearing aid devices and equipment industry. This hearing aid devices and equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry

The ENT devices are used in the diagnosis and treatment of ear, nose, and throat diseases. The main types of ENT devices are hearing aid devices and equipment, hearing diagnostic devices and equipment, ENT surgical devices and equipment, hearing implants, voice prosthesis devices and equipment, and nasal splints. A hearing aid device is an electronic device that is worn in or behind the ear. It makes sounds louder so that a person with hearing loss can listen, communicate, and participate fully in daily activities. The type of expenditure is public and private. The products used are instruments/equipment and disposables. The various end-users are hospitals and clinics, diagnostic laboratories, and others. The global ent devices market is segmented - 1) By Type: Hearing Aid Devices And Equipment, Hearing Diagnostic Devices And Equipment, ENT Surgical Devices And Equipment, Hearing Implants, Voice Prosthesis Devices And Equipment, Nasal Splints 2) By End User: Hospitals And Clinics, Diagnostic Laboratories, Other End Users 3) By Type of Expenditure: Public, Private 4) By Product: Instruments/Equipment, Disposables The global ent devices market size grew from $30.21 billion in 2022 to $32.98 billion in 2023 at a compound annual growth rate (CAGR) of 9.2%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of global ent devices is expected to grow to $45.04 billion in 2027 at a CAGR of 8.1%. Many governments across the world have introduced new healthcare acts and continuously increased healthcare spending. Healthcare coverage and expenditure also increased significantly. In 2021, the Indian government launched Ayushman Bharat PradhanMantri Jan ArogyaYojana (AB-PMJAY) is providing health assurance cover of up to ?5 Lakh per year per family for secondary and tertiary healthcare hospitalizations. Favourable government decisions and increased healthcare spending increased the demand for healthcare services and this drove the demand for the growth of the ENT devices market during this period. Major companies in the ENT devices market include Sonova Holdings AG, William Demant Holdings A/S, Medtronic Inc., GN Store Nord A/S, Cochlear Limited, Olympus Corporation, Stryker Corporation, Karl Storz SE & Co KG, Merck & Co, and Smith & Nephew plc. Interest rates globally are forecasted to rise in most of the developing and developed economies during the forecast period; this is expected to limit new investments in the market. Most countries across the world are raising interest rates to control inflation and also to limit the flow of capital out of the country. This is likely to affect new investments in terms of expansion, research, and development of new products. For instance, the US interest rates are expected to rise to 3.5% by 2021. These factors are expected to have a negative impact on the market as borrowing money becomes expensive, thereby affecting the market growth. ENT device manufacturers are investing in technologies to develop user-friendly and non-invasive equipment. They are continuously investing funds and resources into R&D to increase the scope of their devices. For instance, Intersect ENT developed Propel Mometasone Furoate Implant (PMFI) to treat chronic sinusitis. It is a bio-absorbable steroid that is placed directly into the sinus mucosa. It controls the release of drugs and dissolves over time. In another breakthrough in sinusitis treatment, SinuSys Corporation received FDA approval for its Vent-Os Sinus Dilation device. It is a small, low-pressure insert that is designed to gently open the sinus ostia and use the body’s natural mucosal fluids to expand the device. Asia-Pacific was the largest region in the global ENT devices market in 2022. North America was the second largest region in the global ENT devices market share. Africa. was the smallest region in the global ENT devices market analysis. The regions covered in the ENT devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the ENT devices market are Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa., South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, UAE, UK, USA, Venezuela, and Vietnam. The ENT devices market consists of sales of instruments such as Pure tone and impedance audiometers, BERA and OAE screening machines, nerve stimulators, and high-end microdrill that are used for diagnosis and treatment of ENT diseases. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The ENT devices market research report is one of a series of new reports from The Business Research Company that provides ENT devices market statistics, including ENT devices industry global market size, regional shares, competitors with an ENT devices market share, detailed ENT devices market segments, market trends and opportunities, and any further data you may need to thrive in the ENT devices industry. This ENT devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

3D printed medical devices are artificial devices that replace a missing body part or biological structure and are manufactured by laying successive layers of material using inputs from a digital 3D model. The main types of 3D printed medical devices are implants, surgical instruments, prosthetics, tissue engineering devices, and others. The 3D-printed implants are medical implants that are made using 3D printing technology to create complex geometries. These are made up of raw materials such as plastics, biomaterial inks, and metals and alloys. The technologies involved in 3D printed medical devices are fused deposition modeling, digital light processing, stereolithography, and selective laser melting. These provide applications in orthopedic, spinal, dental, hearing aids, and others that are used by end-users such as hospitals, diagnostics centres, academic institutions, and others. The global 3D printed medical devices market is segmented – 1) By Type: Implants, Surgical instruments, Prosthetics, Tissue engineering devices, Other Types 2) By Application: Orthopedic, Spinal, Dental, Hearing Aids, Other Applications 3) By Technology: Fused Deposition Modelling, Digital Light Processing, Stereolithography, Selective Laser melting 4) By Raw Material: Plastics, Biomaterial inks, Metals and Alloys 5) By End User: Hospitals, Diagnostics Centres, Academic Institutions, Other End Users The global 3d printed medical devices market size grew from $2.87 billion in 2022 to $3.57 billion in 2023 at a compound annual growth rate (CAGR) of 24.5%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of global 3d printed medical devices is expected to grow to $9.09 billion in 2027 at a CAGR of 26.3%. The increasing prevalence of osteoarthritis and similar musculoskeletal conditions is one of the major factors driving the growth of the 3D printed medical devices market. Osteoarthritis is a disorder that damages the joint cartilage and surrounding tissues causing pain, stiffness, and loss of joint function to the person affected by it. The 3D printing medical devices enable the creation of a replica of a patient's joint, which can provide surgeons with a crucial piece of information that might not be visible on a 2-dimensional scan. The chance of developing osteoarthritis increases with age. For instance, according to the US National Library of Medicine report, by 2040, it is estimated that approximately 78 million (26%) US adults aged 18 years and above will be projected to have doctor-diagnosed arthritis. Thereby driving the adoption of 3D printed medical devices, positively impacting the 3d printed medical devices market growth. Major players in the 3D printed medical devices market are 3D Systems Corporation, EnvisionTEC, Stratasys Ltd., Arcam AB, Cyfuse Biomedical, Materialise NV, Organovo Holdings, EOS GmbH, FabRx Ltd., and Concept Laser. Biocompatibility issues related to 3D printed medical devices restrict the growth of the 3D printed medical devices market. Biocompatibility implies the properties that make a material or a device compatible with the human body. If the material used for the preparation of a 3D printed implant device is not compatible with the patients' biomechanics, then patients may suffer side effects such as abnormal growth of bone and bleeding. Among the most common metal used in the manufacturing of 3D printed medical devices is Titanium. Though Titanium offers reliability and accuracy in creating medical-grade products, some human bodies tend to reject titanium as its chemical composition can inhibit the bone and tissue from interacting with the implant. Apart from these other reasons which may contribute to the failure of metallic implants that are either caused by the material properties of the metal (e.g., high stiffness, high corrosion rate, and toxicity) itself or by the exposure of the bone to infected metal implants i.e., infection. The increasing use of 3D printing technology in the spine industry is one of the latest trends in the 3D printed medical devices market. The spine industry is adopting 3D printing to produce new innovative products that can promote bone ingrowth and improve implant fixation to spine bone, reducing the number of manufacturing steps, thereby making the 3D printing process more cost-effective in several cases. For instance, Medtronic launched its titanium 3D printed platform – TiONIC Technology. TiONIC Technology is a 3D printed technique that uses laser methods to create implants with enhanced surface textures. Artic-L is the first implant created by the company using TiONIC Technology. The implant is made up of titanium and is designed to be used by surgeons in spine surgery. In addition to that, K2M’s Lamellar, introduced its 3D Titanium Technology to create a 3D spinal implant. The 3D printing medical device using titanium technology uses an advanced 3D printing method to create structures that were once considered impractical with traditional manufacturing techniques. The implants use titanium powder and are associated with bone growth activity. Food and Drug Administration (FDA) has a Centre for Device and Radiological Health (CDRH) to regulate the firm which manufacture, repackage, relabel and/or import 3D printing medical devices in the US. FDA provides manufacturers with a draft with guidance that includes recommendations for device design, manufacturing, and testing considerations during the development of 3D printing medical devices. Section F of the 'Technical Considerations for Additive Manufactured Medical Device' draft, requires the manufacturers to evaluate the biocompatibility of the final finished device as described in the guidance "Use of International Standard ISO-10993". The guidelines also require the manufacturer of the 3D printing devices to mention the additional information in the label if any toxic chemical additives such as certain additives, catalysts, binding and curing agents, uncured monomers, and plasticizers are used in making 3D printing medical devices. In July 2020, Medtronic, an American Irish-domiciled medical device company acquired Medicrea International for an undisclosed amount. The acquisition of Medicrea expands Medtronic’s already deep portfolio as this adds to their spinal solution profile as the advent of new digital technology will offer the ability to custom spinal implants. Medicrea International is a spinal surgery company with 30+ FDA-approved spinal implant technologies that have been utilized in over 150,000 spinal surgeries to date. North America was the largest region in the 3D printed medical devices market in 2022. Western Europe was the second largest region in the 3D printed medical devices market. The regions covered in the 3D printed medical devices market analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the 3D printed medical devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA. The 3D printed medical devices market consists of sales of 3D printed prosthetics and implants. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The 3D printed medical devices market research report is one of a series of new reports from The Business Research Company that provides 3D printed medical devices market statistics, including 3D printed medical devices industry global market size, regional shares, competitors with a 3D printed medical devices market share, detailed 3D printed medical devices market segments, market trends and opportunities, and any further data you may need to thrive in the 3D printed medical devices industry. This 3D printed medical devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Medical equipment are devices that can be instrument, apparatus or machine that can be used in the prevention, diagnosis or treatment of illness or disease, or for detecting, measuring, restoring, correcting or modifying the structure or function of the body for health purpose. The main types of medical equipment are in-vitro diagnostics, dental equipment and supplies, ophthalmic devices, diagnostic imaging equipment, cardiovascular devices, hospital supplies, surgical equipment, orthopedic devices, patient monitoring devices, diabetes care devices, nephrology and urology devices, ENT devices, anesthesia and respiratory devices, neurology devices, and wound care devices. In-vitro diagnostics are tests done on samples like blood or tissue that is taken from the human body. In-vitro diagnostics will detect diseases or other conditions and are used to monitor a person’s overall health to cure, treat, or prevent diseases. The type of expenditure involved is public and private. The various product are instruments/equipment and disposables. The various end users involved are hospitals and clinics, homecare, diagnostics centres, and others. The global medical equipment market is segmented - 1) By Type: In-Vitro Diagnostics, Dental Equipment And Supplies, Ophthalmic Devices, Diagnostic Imaging Equipment, Cardiovascular Devices, Hospital Supplies, Surgical Equipment, Orthopedic Devices, Patient Monitoring Devices, Diabetes Care Devices, Nephrology And Urology Devices, ENT Devices, Anesthesia And Respiratory Devices, Neurology Devices, Wound Care Devices 2) By Type of Expenditure: Public, Private 3) By Product: Instruments/Equipment, Disposables 4) By End User: Hospitals And Clinics, Homecare, Diagnostics Centers, Other End Users Subsegments Covered: Point-of-Care Diagnostics Devices And Equipment, Immunochemistry Diagnostic Devices And Equipment, Clinical Chemistry Diagnostics Devices And Equipment, Molecular Diagnostics Devices And Equipment, Microbiology Diagnostic Devices And Equipment, Hemostasis Diagnostic Devices And Equipment, Hematology Diagnostic Devices And Equipment, Immunohematology Diagnostic Devices And Equipment, Therapeutic Dental Equipment, General Dental Devices And Equipment, Dental Diagnostic Imaging Devices And Equipment, Dental Surgical Devices And Equipment, Vision Care Devices And Equipment, Cataract Surgery Devices And Equipment, Refractive Surgery Devices And Equipment, Diagnostic And Monitoring Ophthalmic Devices And Equipment, X-Ray Systems Devices And Equipment, Ultrasound Systems Devices And Equipment, Computed Tomography (CT) Scanners Devices And Equipment, Magnetic Resonance Imaging Systems Devices And Equipment, Cardiovascular Monitoring And Diagnostic Devices And Equipment, Nuclear Imaging Devices And Equipment, Cardiovascular Surgery Devices And Equipment, Cardiac Rhythm Management (CRM) Devices And Equipment, Interventional Cardiology Devices And Equipment, Defibrillator Devices And Equipment, Peripheral Vascular Devices And Equipment, Prosthetic Heart Valve Devices And Equipment, Electrophysiology Devices And Equipment, Cardiac Assist Devices And Equipment, Disposable Hospital Supplies, Sterilization Equipment And Disinfectants, Mobility Aids And Transportation Equipment, Operating Room Equipment, Surgical Sutures And Staples, Handheld Surgical Devices And Equipment, Electrosurgical Devices And Equipment, Joint Reconstruction Devices And Equipment, Spinal Surgery Devices And Equipment, Trauma Fixation Devices And Equipment, Orthobiologics Devices And Equipment, Arthroscopy Devices And Equipment, Orthopedic Braces And Support Devices And Equipment, Craniomaxillofacial (CMF) Devices And Equipment, Orthopedic Prosthetics, Orthopedic Accessories,, Fetal And Neonatal Monitoring Devices, Weight Monitoring And Body Temperature Monitoring Devices And Equipment, Vital Parameter Monitoring Devices And Equipment, Remote Patient Monitoring Devices And Equipment, Blood Glucose Test Strips, Insulin Pens, Syringes, Pumps And Injectors, Lancing Devices And Equipment, Continuous Glucose Monitoring Devices And Equipment, Blood Glucose Meters, Dialysis Devices And Equipment, Urinary Stone Treatment Devices And Equipment, Urinary Incontinence & Pelvic Organ Prolapse Devices And Equipment, Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment, Endoscopy Devices And Equipment, Hearing Aid Devices And Equipment, Hearing Diagnostic Devices And Equipment, ENT Surgical Devices And Equipment, Hearing Implants, Voice Prosthesis Devices And Equipment, Nasal Splints, Respiratory Devices And Equipment (Therapeutic And Diagnostic), Anesthesia Machines, Anesthesia Disposables, Respiratory Disposables, Cerebrospinal Fluid Management (CSF) Devices And Equipment, Interventional Neurology Devices And Equipment, Neurosurgery Devices And Equipment, Neurostimulation Devices, Traditional Adhesive Dressings, Negative-pressure Wound Therapy (NPWT), Traditional Gauze Dressings, Advanced Wound Care Devices The global medical equipment market grew from $639.75 billion in 2022 to $695.05 billion in 2023 at a compound annual growth rate (CAGR) of 8.6%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of global medical equipment is expected to grow to $922.39 billion in 2027 at a CAGR of 7.3%. The rise in sedentary jobs, busy lifestyles, and changing consumer preferences are affecting the disease profile of the world population, especially non-communicable diseases such as cancer, diabetes, and cardiovascular diseases. Long working hours, less physical activity, and unhealthy eating and drinking habits are major causes of chronic diseases such as diabetes. According to the World Health Organization, chronic disease prevalence is expected to rise by 57% globally, by the year 2020. This is increasing the demand for medical devices used in the diagnosis, prognosis, and treatment of several diseases, thereby driving the demand for medical equipment. These factors are expected to increase the patient pool globally, thereby driving the growth of the medical equipment market during the forecast period. Major companies in the medical equipment market include Medtronic Inc., Abbott Laboratories, Johnson & Johnson, Cardinal Health, Inc., Becton Dickinson, Siemens AG, STRYKER CORPORATION, Koninklijke Philips N.V., F. Hoffmann-La Roche Ltd., and Boston Scientific Corporation. Regulatory changes are likely to lead to increased costs relating to new product development and service offerings to clients. These changes are related to customer data protection such as the European Union's General Data Protection Regulation (GDPR), changes to equipment approval procedures, and other regulatory changes. For instance, according to cookieyed data 2021, in the US, PwC reported that 68% of 200 businesses surveyed intended to spend between $1 million and $10 million to comply with GDPR regulations. The GDPR regulation is an EU law on data protection and privacy of individuals residing in the European Union and the European Economic Area (EEA). It also regulates the export of personal data outside the EU and EEA areas. Additionally, the FDA is requesting more clinical data to support claims, therefore increasing the time to process 510(k)s by over 55% over the last decade. The potential loss of revenue due to delays in product release and additional costs incurred due to stringent approval processes puts a strain on investments relating to new product development, thereby affecting the growth of the medical equipment market. Device performance and patient data are available to healthcare service providers and are helping them to improve patient monitoring and overall care quality. Some companies are integrating medical equipment market data with EMR (Electronic Medical Records) to improve transparency and collaboration. As consumer wearables are becoming more common, patient data volumes are increasing and companies are investing in deploying data management, warehousing, and security technologies. For example, Medtronic launched a tool to augment their cardiac devices to securely transfer device data to doctors and allow them to monitor the critical health indicators of their patients. North America was the largest region in the global medical equipment market in 2022. Asia-Pacific was the second largest region in the global medical equipment market share. The regions covered in the medical equipment market analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the medical equipment market are Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa., South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, UAE, UK, USA, Venezuela, and Vietnam. The medical equipment market consists of sales of devices used in the diagnosis, treatment and monitoring of medical conditions. The market includes diagnostic devices, imaging devices, surgical devices and patient monitoring devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in the medical equipment market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified medical equipment market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the medical equipment market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The medical equipment market research report is one of a series of new reports from The Business Research Company that provides medical equipment market statistics, including medical equipment industry global medical equipment market size, regional shares, competitors with a medical equipment market share, detailed medical equipment market segments, medical equipment market trends and opportunities, and any further data you may need to thrive in the medical equipment industry. This medical equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.